Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Lexaria Bioscience (LEXX.US)$ NEWS Lexaria Receives Two New...

NEWS
Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
Lexaria Bioscience has announced the receipt of two new US patents in the medical fields of hypertension and epilepsy. The first patent, part of Lexaria's patent family #21, focuses on compositions and methods for treating hypertension using DehydraTECH-processed cannabidiol (CBD). The second patent, part of patent family #24, pertains to treating epilepsy, highlighting DehydraTECH-CBD's efficacy in mitigating epileptic seizures and its superior absorption compared to Epidiolex. Both patents are valid until 2042. Lexaria now holds a total of 43 patents globally, reinforcing its strategic business objectives.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
1732 Views
Comment
Sign in to post a comment
    Spread kindness and love. Life is short. Don’t let greed eat you.
    833Followers
    62Following
    5553Visitors
    Follow